Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AVXL

Anavex Life Sciences (AVXL)

Anavex Life Sciences Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVXL
DateTimeSourceHeadlineSymbolCompany
04/19/20245:45AMPR Newswire (US)Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)NASDAQ:AVXLAnavex Life Sciences Corporation
04/16/20245:45AMPR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
04/12/20245:45AMPR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
04/11/20247:30AMGlobeNewswire Inc.Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
04/09/20245:45AMPR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
04/05/20245:45AMPR Newswire (US)Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
04/02/20245:45AMPR Newswire (US)Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
03/29/20245:45AMPR Newswire (US)Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
03/26/20245:45AMPR Newswire (US)Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
03/25/20247:30AMGlobeNewswire Inc.Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
03/22/20245:45AMPR Newswire (US)AVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:AVXLAnavex Life Sciences Corporation
03/18/20247:30AMGlobeNewswire Inc.Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
02/26/20247:30AMGlobeNewswire Inc.Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20246:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20246:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20246:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20246:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20246:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/07/20244:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVXLAnavex Life Sciences Corporation
02/07/20247:30AMGlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
02/01/20247:30AMGlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
01/25/20245:01PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVXLAnavex Life Sciences Corporation
01/24/20247:30AMGlobeNewswire Inc.Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in HumansNASDAQ:AVXLAnavex Life Sciences Corporation
01/16/20247:30AMGlobeNewswire Inc.Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
01/12/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
01/08/20247:30AMGlobeNewswire Inc.Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental DisordersNASDAQ:AVXLAnavex Life Sciences Corporation
01/03/20247:30AMGlobeNewswire Inc.Anavex to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
01/02/20248:00AMGlobeNewswire Inc.Anavex Life Sciences Provides an Update on Rett Syndrome ProgramNASDAQ:AVXLAnavex Life Sciences Corporation
12/20/20237:30AMGlobeNewswire Inc.Anavex Announces First Entire Clinical Gene Pathway Data of ANAVEX®2-73 from AVATAR Study in Patients with Rett SyndromeNASDAQ:AVXLAnavex Life Sciences Corporation
12/19/20237:30AMGlobeNewswire Inc.Anavex Received Agreement from the Committee for Medicinal Products for Human Use (CHMP) for the Submission of a Marketing Authorisation Application of Oral Blarcamesine for Alzheimer’s DiseaseNASDAQ:AVXLAnavex Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:AVXL